BioSyent Inc. (CVE:RX)’s quarterly earnings will be reported on March, 20., according to RTT. This year’s earnings per share analyst estimate is anticipated to be $0.11. That is 10.00 % up compareed to $0.1 earnings per share for last year. If reported the P/E will be 18.41 with $1.58M profit. Wall Street now sees 22.22 % EPS growth despite BioSyent Inc. previous quarter’s EPS of $0.09. The last price was $8.1.Since February 19, 2018 it’s 0.00% down thus . RX by 0.00% the S&P 500.
BioSyent Inc., a specialty pharmaceutical company, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally.The company has $116.54 million market cap. The Company’s products include FeraMAX 150, an oral hematinic for the prevention and treatment of iron deficiency anaemia; FeraMAX Powder, a water soluble oral iron supplement, which helps the body form red blood cells; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by menopause, stress, and chemotherapy; Proktis-M, a rectal suppository to help healing of the anus and rectum; Aguettant System for pre-filled syringes that are used for various injectable medications in hospital and acute care settings; and Cysview for the detection and management of papillary non-muscle invasive bladder cancer.21.43 is the P/E ratio. The company’s products also comprise Cathejell Jelly 2% indicated for surface anesthesia and lubrication for various procedures, including male and female cystoscopies, catheterizations, and other endourethral operations; and endoscopies, proctoscopies, rectoscopies, and tracheal intubations, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis.
For more BioSyent Inc. (CVE:RX) news posted recently go to: Profitconfidential.com, Cleveland.com, Midasletter.com, Profitconfidential.com or Midasletter.com. The titles are as follows: “Marijuana Market: Top Pot Stock Winners and Losers of the Week – Profit Confidential” posted on February 22, 2018, “Brunswick residents respond to construction runoff – cleveland.com” on April 10, 2018, “VIDEO: Aphria Inc (TSE:APH) CEO Vic Neufeld on Altria Group Inc (NYSE:MO) Rumours – Midas Letter” with a publish date: October 15, 2018, “Marijuana Stocks in 2018: How ACB, WEED, and APH Have Fared So Far – Profit Confidential” and the last “Aurora Cannabis Inc (TSE:ACB) CCO Cam Battley on Spin-out and Canopy Growth Corp – Constellation Brands Tie-up – Midas Letter” with publication date: August 18, 2018.